Related Experiment Videos
Annular subacute cutaneous lupus erythematosus responsive to dapsone
Journal of the American Academy of Dermatology
|September 1, 1984
Summary
Dapsone effectively treated two patients with subacute cutaneous lupus erythematosus (SCLE). This treatment prevented new lesions and led to complete skin eruption resolution.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Subacute cutaneous lupus erythematosus (SCLE) is an autoimmune condition affecting the skin.
- Treatment options for SCLE can be limited, necessitating exploration of alternative therapies.
Observation:
- Two patients diagnosed with annular SCLE were selected for this study.
- The patients presented with active skin eruptions characteristic of the condition.
Findings:
- Treatment with dapsone halted the development of new SCLE lesions in both patients.
- Consistent improvement in existing skin lesions was observed.
- Complete resolution of cutaneous eruptions was achieved with dapsone therapy.
Implications:
- Dapsone demonstrates potential as an effective therapeutic agent for subacute cutaneous lupus erythematosus.
- Further research into dapsone's efficacy and safety in a larger SCLE cohort is warranted.
- This finding may offer a new treatment avenue for patients with refractory SCLE.